Table 4 Chemosensitivity testing in 50 soft tissue sarcoma patients
From: Feasibility of chemosensitivity testing in soft tissue sarcomas
Cytotoxics | Resistant | Low Sensitivity | Moderate Sensitivity | High Sensitivity | Mean Sensitivity Index* |
|---|---|---|---|---|---|
Actinomycin D | 00/50 (00%) | 10/50 (20%) | 03/50 (06%) | 37/50 (74%) | 137 |
Doxorubicin (Adriamycin) | 03/50 (06%) | 02/50 (04%) | 10/50 (20%) | 35/50 (70%) | 140 |
Ifosfamide | 10/50 (32%) | 00/50 (00%) | 02/50 (04%) | 32/50 (64%) | 234 |
Epirubicin | 08/50 (16%) | 00/50 (00%) | 12/50 (24%) | 30/50 (60%) | 245 |
Cisplatin | 39/50 (82%) | 11/50 (22%) | 00/50 (00%) | 00/50 (00%) | 444 |
Dacarbazine | 45/50 (95%) | 05/50 (5%) | 00/50 (00%) | 00/50 (00%) | 532 |
Vincristine | 42/50 (84%) | 08/50 (16%) | 00/50 (00%) | 00/50 (00%) | 513 |
Doxorucicin + Ifosfamide | 03/50 (06%) | 00/50 (00%) | 11/50 (22%) | 36/50 (72%) | 139 |
Actinomycin D + Ifosfamide | 01/50 (2%) | 08/50 (16%) | 03/50 (06%) | 38/50 (76%) | 163 |
VAC** | 03/50 (06%) | 05/50 (10%) | 07/50 (14%) | 35/50 (70%) | 218 |
CYVADIC*** | 02/50 (04%) | 00/50 (00%) | 15/50 (30%) | 33/50 (66%) | 255 |